Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. In news ...

New York, June 20, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of subcutaneous (SC) Vyvgart Hytrulo (efgartigimod ...

In a recent study published in the Scientific Reports Journal, researchers examined the therapeutic potential of an injectable copolymer of stearic, palmitic, and oleic acids known as ARA 3,000 BETA ...

A new drug could help people taking GLP-1 obesity drugs avoid muscle loss that often accompanies rapid weight loss.